Amuvatinib 50 mg | Purity Not Available
TargetMol
Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.
More Information Supplier PageAmuvatinib
Search Results
Amuvatinib 2 mg | Purity Not Available
TargetMol
Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.
More Information Supplier PageAmuvatinib
Amuvatinib 10 mg | Purity Not Available
TargetMol
Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.
More Information Supplier PageAmuvatinib
Seliciclib 200 mg | 100.00%
TargetMol
Seliciclib (Roscovitine) is a potent inhibitor of Cdk2/cyclin E (IC50: 0.1 μM). It also inhibits Cdk7/cyclin H, Cdk5/p35, and Cdc2/cyclin B (IC50s: 0.49/0.16/0.65 μM).
More Information Supplier PageSeliciclib
Seliciclib 100 mg | 100.00%
TargetMol
Seliciclib (Roscovitine) is a potent inhibitor of Cdk2/cyclin E (IC50: 0.1 μM). It also inhibits Cdk7/cyclin H, Cdk5/p35, and Cdc2/cyclin B (IC50s: 0.49/0.16/0.65 μM).
More Information Supplier PageSeliciclib
Parthenolide 100 mg | 99.33%
TargetMol
(-)-Parthenolide, an inhibitor of the Nuclear Factor-κB Pathway, also promotes the ubiquitination of MDM2 and activates p53 cellular functions.
More Information Supplier PageParthenolide
Parthenolide 200 mg | 99.33%
TargetMol
(-)-Parthenolide, an inhibitor of the Nuclear Factor-κB Pathway, also promotes the ubiquitination of MDM2 and activates p53 cellular functions.
More Information Supplier PageParthenolide
Parthenolide 50 mg | 99.33%
TargetMol
(-)-Parthenolide, an inhibitor of the Nuclear Factor-κB Pathway, also promotes the ubiquitination of MDM2 and activates p53 cellular functions.
More Information Supplier PageParthenolide
Bisdemethoxycurcumin 5 mg | Purity Not Available
TargetMol
Bisdemethoxycurcumin (Curcumin III) is a natural demethoxy derivative of curcumin. It is a potent activator of macrophage phagocytosis, interacting with 1α, 25-dihydroxy vitamin D3 to stimulate amyloid-β clearance by macrophages (optimal stimulation at 100 nM BDMC) [1]. More stable than curcumin in physiological media, BDMC suppresses proliferation of cancer cells [2]. It down-regulates the transcriptional […]
More Information Supplier PageBisdemethoxycurcumin
Bestatin 10 mg | Purity Not Available
TargetMol
Bestatin (Ubenimex) competitively inhibits many aminopeptidases, including B, N and leucine aminopeptidases. Ubenimex is a microbial metabolite and dipeptide with potential immunomodulatory and antitumor activities. Aminopeptidases has been implicated in the process of cell adhesion and invasion of tumor cells. Therefore, inhibiting aminopeptidases may partially attribute to the antitumor effect of ubenimex. This agent also […]
More Information Supplier PageBestatin
